Insurance companies should cover treatment, not only emergency intervention, when someone is already in crisis
At the opening of the 2023 annual meeting of the American Heart Association in Philadelphia, results of a clinical trial generated tremendous interest: Semaglutide, it appeared, was a new tool to treat heart disease
Managing type 2 diabetes necessitates thorough and frequent clinical assessment, from blood glucose monitoring to A1C testing
Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid
AuNR response to concentration of l- or d-carnitine In order to further evaluate the recognition performance of AuNRs, we investigated the absorption change of AuNRs caused by various concentrations of d-carnitine or l-carnitine
A short course of anti-nausea medication can carry someone through a hard week of titration